Expertise in
1
conditions

Kao-pin S. Hwang

Taitung, TNQ, TW 
Expertise in
1
conditions
Taitung, TNQ, TW 

Overview

Kao-pin Hwang practices practicing medicine in Taitung, Taiwan.

Hwang is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Herpangina, Pinworms, and Osteomyelitis in Children.

They are actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 3 clinical trials.

Locations

Taitung, TNQ, Taiwan
Other Locations
Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I, Open-Label Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 Vaccine in Healthy Adult Volunteers
A Phase I, Open-Label Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 Vaccine in Healthy Adult Volunteers
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Biological
Study Drug: UB-612
Study Phase: Phase 1
A Phase I, Open-label Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 Vaccine in Healthy Adult Volunteers
A Phase I, Open-label Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 Vaccine in Healthy Adult Volunteers
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Biological
Study Drug: UB-612 S1-RBD-Protein-Based Vaccine
Study Phase: Phase 1
A Phase II, Placebo-controlled, Randomized, Observer-blind Study to Evaluate the Immunogenicity, Safety, and Tolerability of UB-612 Vaccine Against COVID-19 in Adolescent, Younger and Elderly Adult Volunteers
A Phase II, Placebo-controlled, Randomized, Observer-blind Study to Evaluate the Immunogenicity, Safety, and Tolerability of UB-612 Vaccine Against COVID-19 in Adolescent, Younger and Elderly Adult Volunteers
Enrollment Status: Terminated
Publish Date: August 26, 2022
Intervention Type: Biological
Study Drug: UB-612 S1-RBD-Protein-Based Vaccine
Study Phase: Phase 2
View 2 Less Clinical Trials

43 Total Publications

A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in children.
A randomised trial of a bioreactor-produced EV-A71 vaccine for endemic control in children.
Journal: NPJ vaccines
Published: October 10, 2025

Frequently Asked Questions about Kao-pin S. Hwang

Is Kao-pin S. Hwang a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Kao-pin S. Hwang is classified as an Advanced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kao-pin S. Hwang participate in research or clinical trials?

Yes. Kao-pin S. Hwang has published 43 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Kao-pin S. Hwang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hwang's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile